elranatamab
pfizer
['multiple myeloma', 'elranatamab']
#ash22 | r02-r05 | saturday 12pm cst
elranatamab, a bcma targeted t-cell engaging bispecific antibody, induces durable clinical and molecular responses for patients with relapsed or refractory multiple myeloma 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.